32.51
price down icon0.21%   -0.07
after-market アフターアワーズ: 32.51
loading
前日終値:
$32.58
開ける:
$32.94
24時間の取引高:
1.58M
Relative Volume:
0.65
時価総額:
$4.57B
収益:
-
当期純損益:
$-507.65M
株価収益率:
-7.0674
EPS:
-4.6
ネットキャッシュフロー:
$-616.24M
1週間 パフォーマンス:
-2.23%
1か月 パフォーマンス:
+0.06%
6か月 パフォーマンス:
-60.29%
1年 パフォーマンス:
-56.95%
1日の値動き範囲:
Value
$32.49
$33.62
1週間の範囲:
Value
$32.06
$34.60
52週間の値動き範囲:
Value
$27.66
$121.06

Vaxcyte Inc Stock (PCVX) Company Profile

Name
名前
Vaxcyte Inc
Name
セクター
Healthcare (1173)
Name
電話
650-837-0111
Name
住所
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Name
職員
414
Name
Twitter
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
PCVX's Discussions on Twitter

PCVX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PCVX
Vaxcyte Inc
32.51 4.57B 0 -507.65M -616.24M -4.60
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.20 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
525.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.09 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
551.22 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.07 28.51B 3.81B -644.79M -669.77M -6.24

Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-22 開始されました Cantor Fitzgerald Overweight
2024-12-20 開始されました Goldman Buy
2023-12-07 開始されました Mizuho Buy
2023-04-18 開始されました TD Cowen Outperform
2023-01-03 繰り返されました Needham Buy
2022-12-15 開始されました Guggenheim Buy
2022-11-17 開始されました BTIG Research Buy
2021-12-29 再開されました Jefferies Buy
2021-06-24 再開されました Jefferies Buy
2020-07-07 開始されました BofA Securities Buy
2020-07-07 開始されました Cantor Fitzgerald Overweight
2020-07-07 開始されました Needham Buy
すべてを表示

Vaxcyte Inc (PCVX) 最新ニュース

pulisher
Jun 17, 2025

Vaxcyte Holds Annual Stockholders Meeting on Governance - TipRanks

Jun 17, 2025
pulisher
Jun 16, 2025

How To Trade (PCVX) - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 12, 2025

Here’s Why Vaxcyte (PCVX) Sold Off in Q1 - MSN

Jun 12, 2025
pulisher
Jun 10, 2025

Transcript : Vaxcyte, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 01 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Vaxcyte: Sentiment Is Pushing The Shares Down (NASDAQ:PCVX) - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

Cantor Fitzgerald maintains Overweight on Vaxcyte shares By Investing.com - Investing.com Canada

Jun 10, 2025
pulisher
Jun 06, 2025

Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of “Buy” by Analysts - Defense World

Jun 06, 2025
pulisher
Jun 03, 2025

(PCVX) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 03, 2025
pulisher
May 30, 2025

Head to Head Contrast: Vaxcyte (NASDAQ:PCVX) and Beam Therapeutics (NASDAQ:BEAM) - Defense World

May 30, 2025
pulisher
May 29, 2025

Vaxcyte (VCYT) Jumps Over 4.5%: Is This Biotech Eyeing a Return Towards Its $121 High? - Daily Chhattisgarh News

May 29, 2025
pulisher
May 26, 2025

Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking the 286% Potential Upside for Investors - DirectorsTalk Interviews

May 26, 2025
pulisher
May 24, 2025

How the (PCVX) price action is used to our Advantage - news.stocktradersdaily.com

May 24, 2025
pulisher
May 20, 2025

James T. Wassil ’99G ’05G of Vaxcyte Inc., Tells Graduates ‘The Journey Ahead is Yours to Shape’ - Lehigh University

May 20, 2025
pulisher
May 13, 2025

Transcript : Vaxcyte, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

Research Analysts Set Expectations for Vaxcyte Q3 Earnings - Defense World

May 12, 2025
pulisher
May 11, 2025

Leerink Partnrs Brokers Cut Earnings Estimates for Vaxcyte - Defense World

May 11, 2025
pulisher
May 11, 2025

Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 11, 2025
pulisher
May 09, 2025

Is Vaxcyte, Inc. (PCVX) The Best Stock That Will Bounce Back? - MSN

May 09, 2025
pulisher
May 09, 2025

Vaxcyte, Inc. Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

11 Stocks That Will Bounce Back According to Analysts - Insider Monkey

May 08, 2025
pulisher
May 08, 2025

Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight - GuruFocus

May 08, 2025
pulisher
May 07, 2025

Vaxcyte (PCVX) Advances Pneumococcal Vaccine Development | PCVX Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Vaxcyte Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2025
pulisher
May 07, 2025

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Vaxcyte Inc Reports Q1 2025 EPS of -$1.04, Beating Estimates; Net Loss Widens to $140.7 Million - GuruFocus

May 07, 2025
pulisher
May 06, 2025

Oversold Conditions For Vaxcyte (PCVX) - Nasdaq

May 06, 2025
pulisher
May 03, 2025

Vaxcyte (PCVX) Stock Price, News & Analysis - MarketBeat

May 03, 2025
pulisher
May 01, 2025

Vaxcyte appoints new independent director - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

Vaxcyte appoints new independent director By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Vaxcyte (PCVX) Welcomes Former Sanofi CEO to Board of Directors | PCVX Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Vaxcyte (PCVX) Welcomes Former Sanofi CEO to Board of Directors - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board - TipRanks

May 01, 2025
pulisher
May 01, 2025

Vaxcyte adds former Sanofi CEO to its board - Investing.com

May 01, 2025
pulisher
May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors | PCVX Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors - The Manila Times

May 01, 2025
pulisher
Apr 29, 2025

Is Vaxcyte, Inc. (PCVX) the Best Oversold NASDAQ Stock to Buy Right Now? - Yahoo Finance

Apr 29, 2025
pulisher
Apr 29, 2025

11 Oversold NASDAQ Stocks to Buy Right Now - Insider Monkey

Apr 29, 2025
pulisher
Apr 26, 2025

US Stocks Dip As Investors Eye Trump's Tariff Announcements - Finimize

Apr 26, 2025
pulisher
Apr 24, 2025

PCVXVaxcyte, Inc. Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

James T. Wassil ’99G ’05G of Vaxcyte, Inc. Named Lehigh’s 2025 Graduate Commencement and Doctoral Hooding Ceremony Speaker - Lehigh University

Apr 24, 2025
pulisher
Apr 22, 2025

Vaxcyte (PCVX) Gains Attention with Overweight Rating Amid Marke - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Vaxcyte (PCVX) Gains Attention with Overweight Rating Amid Market Shifts | PCVX Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 21, 2025

Vaxcyte (PCVX) Sees Surge in Investor Interest Amid Biotech Buzz - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Vaxcyte (PCVX) Sees Surge in Investor Interest Amid Biotech Buzz | PCVX Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Commit To Buy Vaxcyte At $20, Earn 14.7% Annualized Using Options - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

TD Cowen Keeps Their Buy Rating on Vaxcyte (PCVX) - The Globe and Mail

Apr 21, 2025
pulisher
Apr 18, 2025

When the Price of (PCVX) Talks, People Listen - news.stocktradersdaily.com

Apr 18, 2025
pulisher
Apr 17, 2025

2 ‘Strong Buy’ Growth Stocks That Could Gain More Than 340% - The Globe and Mail

Apr 17, 2025
pulisher
Apr 16, 2025

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Apr 16, 2025

Vaxcyte Inc (PCVX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Vaxcyte Inc (PCVX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
GUGGENHIME ANDREW
PRESIDENT AND CFO
Apr 07 '25
Option Exercise
20.93
4,777
99,983
131,950
PICKERING GRANT
CHIEF EXECUTIVE OFFICER
Apr 04 '25
Option Exercise
8.96
20,533
183,888
518,775
Eydelman Mikhail
SVP, GEN COUNSEL & CORP SEC
Mar 05 '25
Option Exercise
21.41
5,000
107,050
46,620
Eydelman Mikhail
SVP, GEN COUNSEL & CORP SEC
Mar 05 '25
Sale
70.74
5,000
353,699
41,620
$20.66
price up icon 0.78%
$36.03
price up icon 0.45%
$21.28
price up icon 3.30%
$100.64
price up icon 1.16%
$106.47
price down icon 0.23%
biotechnology ONC
$242.07
price up icon 0.36%
大文字化:     |  ボリューム (24 時間):